Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Nadeu

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Leukemia|July 31, 2020
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemiaFranz J Gassner, Nadja Zaborsky, Ilana Buchumenski, et al.
Blood|March 29, 2023
Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signatureMaria Tsagiopoulou, Vicente Chapaprieta, Nuria Russiñol, et al.
Annals of Hematology|February 25, 2021
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphomaPablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
The Journal of Pathology|January 23, 2022
Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancerSara Lahoz, Ivan Archilla, Elena Asensio, et al.
Scientific Reports|August 14, 2025
C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemiaAlejandra Gonzalez Martinez, Franz Josef Gassner, Dominik Baumgartner, et al.
Blood|November 19, 2020
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigeneticsFerran Nadeu, Romina Royo, Guillem Clot, et al.
Nature|October 10, 2019
The U1 spliceosomal RNA is recurrently mutated in multiple cancersShimin Shuai, Hiromichi Suzuki, Ander Diaz-Navarro, et al.
Blood Cancer Journal|March 7, 2020
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experiencePablo Mozas, Ferran Nadeu, Alfredo Rivas-Delgado, et al.
Archives of Pathology & Laboratory Medicine|November 10, 2022
MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell SarcomasGerard Frigola, Marco Bühler, Marta Marginet, et al.
Hemasphere|June 8, 2026
Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroupsAndrea Combalia, Nuria Vidal-Robau, Ferran Nadeu, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Leukemia|July 31, 2020
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemiaFranz J Gassner, Nadja Zaborsky, Ilana Buchumenski, et al.
Blood|March 29, 2023
Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signatureMaria Tsagiopoulou, Vicente Chapaprieta, Nuria Russiñol, et al.
Annals of Hematology|February 25, 2021
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphomaPablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
The Journal of Pathology|January 23, 2022
Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancerSara Lahoz, Ivan Archilla, Elena Asensio, et al.
Scientific Reports|August 14, 2025
C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemiaAlejandra Gonzalez Martinez, Franz Josef Gassner, Dominik Baumgartner, et al.
Blood|November 19, 2020
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigeneticsFerran Nadeu, Romina Royo, Guillem Clot, et al.
Nature|October 10, 2019
The U1 spliceosomal RNA is recurrently mutated in multiple cancersShimin Shuai, Hiromichi Suzuki, Ander Diaz-Navarro, et al.
Blood Cancer Journal|March 7, 2020
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experiencePablo Mozas, Ferran Nadeu, Alfredo Rivas-Delgado, et al.
Archives of Pathology & Laboratory Medicine|November 10, 2022
MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell SarcomasGerard Frigola, Marco Bühler, Marta Marginet, et al.
Hemasphere|June 8, 2026
Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroupsAndrea Combalia, Nuria Vidal-Robau, Ferran Nadeu, et al.
Pageof 9